Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 28
20
Diseases
68
Unique genes
0.263
Avg. similarity score
Acro-dermo-ungual-lacrimal-tooth syndrome
Most-connected disease (13 links)
Disease
Searched: Muscular dystrophy, congenital, with or without seizures
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Muscular dystrophy, congenital, with or without seizures
Acro-dermo-ungual-lacrimal-tooth syndrome
Ankyloblepharon-ectodermal defects-cleft lip/palate
Limb-mammary syndrome
Rudiger syndrome
Bladder exstrophy
Rapp-hodgkin syndrome
Cleft lip/palate-ectodermal dysplasia syndrome
Bladder exstrophy and epispadias complex
Breast disease
Cleft lip and cleft of alveolar process of maxilla
Congenital foot deformity
Non-syndromic orofacial cleft type 8
Post-operative stroke
Sweat gland neoplasm
Congenital hand deformities
Zlotogora-ogur syndrome
Aarskog-scott syndrome, x-linked
Intellectual developmental disorder, autosomal recessive 65
Vitreous body disease
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Acro-dermo-ungual-lacrimal-tooth syndrome | 13 | 13 | 1 |
| Ankyloblepharon-ectodermal defects-cleft lip/palate | 13 | 13 | 1 |
| Limb-mammary syndrome | 12 | 12 | 1 |
| Rudiger syndrome | 9 | 9 | 1 |
| Bladder exstrophy | 8 | 8 | 21 |
| Rapp-hodgkin syndrome | 8 | 8 | 1 |
| Cleft lip/palate-ectodermal dysplasia syndrome | 6 | 6 | 2 |
| Bladder exstrophy and epispadias complex | 5 | 5 | 27 |
| Breast disease | 5 | 5 | 7 |
| Cleft lip and cleft of alveolar process of maxilla | 5 | 5 | 4 |
| Congenital foot deformity | 5 | 5 | 4 |
| Non-syndromic orofacial cleft type 8 | 5 | 5 | 1 |
| Post-operative stroke | 5 | 5 | 4 |
| Sweat gland neoplasm | 5 | 5 | 3 |
| Congenital hand deformities | 2 | 2 | 8 |
| Zlotogora-ogur syndrome | 2 | 2 | 1 |
| Aarskog-scott syndrome, x-linked | 1 | 1 | 1 |
| Intellectual developmental disorder, autosomal recessive 65 | 1 | 1 | 1 |
| Muscular dystrophy, congenital, with or without seizures | 1 | 1 | 1 |
| Vitreous body disease | 1 | 1 | 2 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| TP63 | 15 / 20 | Acro-dermo-ungual-lacrimal-tooth syndrome, Ankyloblepharon-ectodermal defects-cleft lip/palate, Bladder exstrophy, Bladder exstrophy and epispadias complex and 11 more |
| NECTIN1 | 3 / 20 | Cleft lip and cleft of alveolar process of maxilla, Cleft lip/palate-ectodermal dysplasia syndrome, Zlotogora-ogur syndrome |
| PTHLH | 3 / 20 | Breast disease, Congenital foot deformity, Congenital hand deformities |
| FGD1 | 2 / 20 | Aarskog-scott syndrome, x-linked, Congenital foot deformity |
| GOSR2 | 2 / 20 | Bladder exstrophy, Muscular dystrophy, congenital, with or without seizures |
| ISL1 | 2 / 20 | Bladder exstrophy, Bladder exstrophy and epispadias complex |
| KDM5B | 2 / 20 | Bladder exstrophy and epispadias complex, Intellectual developmental disorder, autosomal recessive 65 |
| LMNA | 2 / 20 | Congenital foot deformity, Congenital hand deformities |
| NCKAP5 | 2 / 20 | Bladder exstrophy, Vitreous body disease |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| WNT ligand biogenesis and trafficking | Reactome | 4 / 25 | 28.3× | 1.09e-5 | 3.12e-4 ✓ sig. |
| Basal cell carcinoma | KEGG | 5 / 63 | 14.0× | 2.73e-5 | 6.73e-4 ✓ sig. |
| Signaling pathways regulating pluripotency of stem cells | KEGG | 6 / 144 | 7.4× | 1.59e-4 | 2.74e-3 ✓ sig. |
| Cushing syndrome | KEGG | 6 / 155 | 6.8× | 2.37e-4 | 3.75e-3 ✓ sig. |
| Hippo signaling pathway | KEGG | 6 / 157 | 6.7× | 2.54e-4 | 3.97e-3 ✓ sig. |
| Melanogenesis | KEGG | 5 / 101 | 8.7× | 2.61e-4 | 4.05e-3 ✓ sig. |
| Breast cancer | KEGG | 5 / 148 | 6.0× | 1.48e-3 | 1.53e-2 ✓ sig. |
| Gastric cancer | KEGG | 5 / 150 | 5.9× | 1.57e-3 | 1.60e-2 ✓ sig. |
| mTOR signaling pathway | KEGG | 5 / 158 | 5.6× | 1.98e-3 | 1.89e-2 ✓ sig. |
| Hepatocellular carcinoma | KEGG | 5 / 170 | 5.2× | 2.72e-3 | 2.38e-2 ✓ sig. |
| Wnt signaling pathway | KEGG | 5 / 174 | 5.1× | 3.01e-3 | 2.54e-2 ✓ sig. |
| EPHA-mediated growth cone collapse | Reactome | 2 / 20 | 17.7× | 5.62e-3 | 3.95e-2 ✓ sig. |
| Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5) | Reactome | 1 / 1 | 177× | 5.66e-3 | 3.96e-2 ✓ sig. |
| Proteoglycans in cancer | KEGG | 5 / 204 | 4.3× | 5.90e-3 | 4.08e-2 ✓ sig. |
| EPH-Ephrin signaling | Reactome | 2 / 22 | 16.1× | 6.78e-3 | 4.45e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| canonical Wnt signaling pathway | GO:0060070 | 7 / 105 | 18.3× | 1.06e-7 | 1.33e-5 ✓ sig. |
| negative regulation of mesenchymal cell proliferation | GO:0072201 | 3 / 6 | 137× | 9.15e-7 | 7.99e-5 ✓ sig. |
| stem cell proliferation | GO:0072089 | 5 / 54 | 25.4× | 1.51e-6 | 1.21e-4 ✓ sig. |
| embryonic hindlimb morphogenesis | GO:0035116 | 4 / 29 | 37.9× | 3.56e-6 | 2.41e-4 ✓ sig. |
| embryonic forelimb morphogenesis | GO:0035115 | 4 / 33 | 33.3× | 6.06e-6 | 3.69e-4 ✓ sig. |
| cell fate commitment | GO:0045165 | 5 / 75 | 18.3× | 7.79e-6 | 4.50e-4 ✓ sig. |
| cloacal septation | GO:0060197 | 2 / 2 | 275× | 1.30e-5 | 6.69e-4 ✓ sig. |
| Wnt signaling pathway | GO:0016055 | 7 / 232 | 8.3× | 2.12e-5 | 9.66e-4 ✓ sig. |
| mesenchymal cell proliferation | GO:0010463 | 3 / 16 | 51.5× | 2.49e-5 | 1.09e-3 ✓ sig. |
| hair follicle development | GO:0001942 | 4 / 48 | 22.9× | 2.77e-5 | 1.18e-3 ✓ sig. |
| skin development | GO:0043588 | 4 / 55 | 20.0× | 4.76e-5 | 1.78e-3 ✓ sig. |
| cartilage condensation | GO:0001502 | 3 / 21 | 39.3× | 5.85e-5 | 2.08e-3 ✓ sig. |
| regulation of cell adhesion | GO:0030155 | 4 / 61 | 18.0× | 7.16e-5 | 2.41e-3 ✓ sig. |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 4 / 67 | 16.4× | 1.03e-4 | 3.17e-3 ✓ sig. |
| animal organ morphogenesis | GO:0009887 | 5 / 130 | 10.6× | 1.11e-4 | 3.32e-3 ✓ sig. |